GSK and ViiV Healthcare to showcase advances across industry-leading infectious disease portfolio at IDWeek 2024
60 abstracts to be presented across broad and growing portfolio of vaccines and medicines aimed at getting ahead of infectious disease New data to be shared on GSK’s RSV vaccine across different age groups of patients at increased risk Efficacy data for …